James Elia

James is a first-year PhD student in the Molecular Medicine, Pharmacology, and Physiology program at Yale School of Medicine. His past research focused on the use of nanoparticles for direct delivery of biologics, including CRISPR/Cas9, siRNA, and various proteins. He is interested in applying this experience to the development of novel therapeutics. His passion for biotech comes from the belief that the best way to get cutting-edge medicine to patients is through the collaboration of academia and industry.